IP Library › Assignment 073790/0484
Patent Assignment
Reel/Frame 073790/0484

Release of Security Interest

Recorded: 2025-12-23 Pages: 33
Assignor
SILICON VALLEY BANK
Executed: 2025-12-19
Assignee
XOMA TECHNOLOGY LTD.
2200 POWELL STREET, SUITE 310, EMERYVILLE, CALIFORNIA, 94608
Covered Properties (219)
Eukaryotic Signal Sequences for Polypeptide Expression and Polypeptide Display Libraries
Methods and Materials for Increasing Expression of Recombinant Polypeptides
Antagonist Anti-CD40 Monoclonal Antibodies and Methods for Their Use
M-Csf Specific Monoclonal Antibody and Uses Thereof
Methods and Materials for Expression of a Recombinant Protein
Use of Antibody to M-Csf
M-Csf Specific Monoclonal Antibody and Uses Thereof
Human Antibodies Specific for Gastrin Materials and Methods
Soluble Human M-Csf Receptor and Uses Thereof
Methods for Preventing and Treating Cancer Metastasis and Bone Loss Associated with Cancer Metastasis
EPHB3-Specific Antibody and Uses Thereof
Prlr-Specific Antibody and Uses Thereof
Antagonist Antibodies Against EPHB3
Methods and Materials for Targeted Mutagenesis
Novel Triple Tag Sequences and Methods of Use Thereof
Antibodies to High Molecular Weight Melanoma Associated Antigen
Anti-Botulism Antibody Coformulations
Antibody Coformulations
Screening Methods
Methods and Materials for Enhancing Functional Protein Expression in Bacteria
Antibodies Specific for Tgf-Beta
Treatment of Cancer Using Inhibitors of Tgf-Beta and Pd-1
Method for Treating Plasma for Transfusion
Patent: 4,664,913 →
Application: 06/632,756 →
Human Melanoma Specific Immunotoxins
Patent: 4,590,071 →
Application: 06/654,613 →
Antibody Hybrid Molecules and Process for Their Preparation
Patent: 4,698,420 →
Application: 06/705,271 →
Hybridoma Tumor Cell Lines and Their Monoclonal Antibodies to Thaumatin
Patent: 4,770,993 →
Application: 06/794,247 →
Method for Isolation of Recombinant Polypeptides in Biologically Active Forms
Patent: 4,766,205 →
Application: 06/797,473 →
Radioimmuno Detection of Human Cancers Using Anti-Tumour Monoclonal Antibody
Patent: 4,708,862 →
Application: 06/875,256 →
Osteogenic Factors
Patent: 4,804,744 →
Application: 06/904,563 →
Peptide Fragments of Human Apolipoprotein, Type-Specific Antibodies and Methods of Use
Patent: 4,970,144 →
Application: 06/905,584 →
Cecropin Polypetides with Activity Against Gram-Positive and Gram- Negative Bacteria
Patent: 5,166,321 →
Application: 07/011,577 →
Hepatic Blocking Agents
Patent: 4,946,675 →
Application: 07/055,266 →
Linking Agents and Methods
Patent: 4,970,303 →
Application: 07/151,700 →
Dna Encoding (Asp 113) and (Lys 46, Asp 113) Thaumatin I
Patent: 5,464,770 →
Application: 07/189,250 →
Dna Encoding (LYS46, ASP97, ASP113) and (LYS46, ASP113, ASP137) Thaumatin I Polypeptides
Patent: 5,221,624 →
Application: 07/407,416 →
Osteogenic Factors
Patent: 5,106,626 →
Application: 07/415,555 →
Process and Device to Fold Strips of Swabs
Patent: 5,057,069 →
Application: 07/443,703 →
Hindered Linking Agents Derived from 2-Iminothiolanes and Methods
Patent: 5,093,475 →
Application: 07/454,576 →
Arab Promoters and Method of Producing Polypeptides, Including Cecropins, by Microbiological Techniques
Patent: 5,028,530 →
Application: 07/474,304 →
Shortened Phosphoglycerate Kinase Promoter
Patent: 5,104,795 →
Application: 07/480,003 →
A Method of Producing Cecropins, by Microbiological Techniques
Patent: 5,206,154 →
Application: 07/637,199 →
Chimeric Antibody with Specificity to Human B Cell Surface Antigen
Patent: 5,500,362 →
Application: 07/665,939 →
Chimeric Antibody with Specificity to Human Tumor Antigen
Patent: 5,354,847 →
Application: 07/759,707 →
Modular Hearing Aid System
Patent: 5,185,802 →
Application: 07/875,531 →
Analogs of Ribosome - Inactivating Proteins
Patent: 5,376,546 →
Application: 07/901,707 →
Materials Comprising and Methods of Preparation and Use for Ribosome-Inactivating Proteins
Patent: 5,416,202 →
Application: 07/988,430 →
Dna Encoding Polypeptides with Activity Against Gram-Positive and Gram-Negative Bacteria
Patent: 5,344,765 →
Application: 08/010,676 →
Stable Bactericidal/Permeability-Increasing Protein Muteins
Patent: 5,420,019 →
Application: 08/013,801 →
Therapeutic Uses of Bactericidal/Permeability Increasing Protein Products
Patent: 5,348,942 →
Application: 08/030,644 →
Modified Antibody Variable Domains
Patent: 5,869,619 →
Application: 08/082,842 →
Modified Antibody Variable Domains
Patent: 5,766,886 →
Application: 08/107,669 →
Method for Quantifying Bpi in Body Fluids
Patent: 5,466,580 →
Application: 08/125,677 →
Method for Quantifying Bpi in Body Fluids
Patent: 5,466,581 →
Application: 08/175,276 →
Method for Quantifying Lipopolysacchande Binding Protein
Patent: 5,484,705 →
Application: 08/186,811 →
Pharmaceutical Composition Comprising Bpi Proteins
Patent: 5,488,034 →
Application: 08/190,869 →
Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof
Patent: 5,733,872 →
Application: 08/209,762 →
Therapeutic Uses of Bactericidal/Permeability-Increasing Protein Dimer Products
Patent: 5,447,913 →
Application: 08/212,132 →
Method of Treating Conditions Associated with Intestinal Ischemia/Reperfusion
Patent: 5,578,568 →
Application: 08/232,527 →
Modular Assembly of Antibody Genes, Antibodies Prepared Thereby and Use
Patent: 5,618,920 →
Application: 08/235,225 →
Bactericidal/Permeability-Increasing Protein (Bpi) Compositions
Patent: 5,932,544 →
Application: 08/251,576 →
Lipopolysaccharide Binding Protein Derivatives
Patent: 5,731,415 →
Application: 08/261,660 →
Anti-Protozoan Methods
Patent: 5,646,114 →
Application: 08/273,470 →
Method for Potentiating Bpi Protein Product Bactericidal Activity by Administration of Lbp Protein Products
Patent: 5,770,561 →
Application: 08/274,303 →
Modular Assembly of Antibody Genes Antibodies Prepared Thereby and Use
Patent: 5,595,898 →
Application: 08/299,085 →
Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof
Patent: 5,652,332 →
Application: 08/306,473 →
Method of Screening for an Active Inflammatory State by Determining the Concentration of Extracellular Bpi
Patent: 5,821,064 →
Application: 08/310,961 →
Method of Treating Gram-Negative Bacterial Infection by Administration of Bactericidal/Permeability-Increasing (Bpi) Protein Product and Antibiotic
Patent: 5,523,288 →
Application: 08/311,611 →
Novel Vectors with Pectate Lyase Signal Sequence
Patent: 5,576,195 →
Application: 08/357,234 →
Anti-Fungal Methods and Materials
Patent: 5,627,153 →
Application: 08/372,105 →
Anti-Gram-Positive Bacterial Methods and Materials
Patent: 5,578,572 →
Application: 08/372,783 →
Method for Quantifying Lbp in Body Fluids
Patent: 5,804,367 →
Application: 08/377,391 →
Method of Treating Conditions Associated with Burn Injuries
Patent: 5,494,896 →
Application: 08/414,924 →
Immunotoxins Comprising Ribosome-Inactivating Proteins
Patent: 5,621,083 →
Application: 08/425,336 →
Modular Assembly of Antibody Genes, Antibodies Prepared Thereby and Use
Patent: 5,693,493 →
Application: 08/450,731 →
Production of Chimeric Mouse-Human Antibodies with Specificity to Human Tumor Antigens
Patent: 5,843,685 →
Application: 08/466,034 →
Modular Assembly of Antibody Genes, Antibodies Prepared Thereby and Use
Patent: 5,698,417 →
Application: 08/466,203 →
Modular Assembly of Antibody Genes, Antibodies Prepared Thereby and Use
Patent: 5,698,435 →
Application: 08/467,140 →
Production of Chimeric Antibodies with Specificity to Human Tumor Antigens
Patent: 6,461,824 →
Application: 08/467,142 →
Chimeric Antibody with Specificity to Human B Cell Surface Antigen
Patent: 5,677,180 →
Application: 08/469,916 →
Chimeric Antibody with Specificity to Human B Cell Surface Antigen
Patent: 5,721,108 →
Application: 08/471,984 →
Modular Assembly of Antibody Genes Antibodies Prepared Thereby and Use
Patent: 6,204,023 →
Application: 08/472,691 →
Pectate Lyase Signal Sequence
Patent: 5,846,818 →
Application: 08/472,696 →
Modified Antibody Variable Domains and Therapeutic Uses Thereof
Patent: 5,770,196 →
Application: 08/472,788 →
Immunotoxins Comprising Ribosome-Inactivating Proteins
Patent: 5,756,699 →
Application: 08/477,484 →
Modified Antibody Variable Domains and Therapeutic Uses Thereof
Patent: 5,821,123 →
Application: 08/477,531 →
Immunotoxins Comprising Ribosome-Inactivating Proteins
Patent: 5,744,580 →
Application: 08/488,113 →
Methods of Treating Conditions Associated with Corneal Transplantation
Patent: 5,686,414 →
Application: 08/557,287 →
Anti-Fungal Peptides
Patent: 5,858,974 →
Application: 08/621,259 →
Methods for Recombinant Microbial Production of Fusion Proteins and Bpi-Derived Peptides
Patent: 5,851,802 →
Application: 08/621,803 →
Antithrombotic Materials and Methods
Patent: 5,741,779 →
Application: 08/644,290 →
Polynucleotides Encoding Gelonin Sequences
Patent: 5,837,491 →
Application: 08/646,360 →
Anti-Chlamydial Uses of Bpi Protein Products
Patent: 5,888,973 →
Application: 08/694,843 →
Method for Quantifying Lbp in Body Fluids
Patent: 5,891,618 →
Application: 08/779,400 →
Immunotoxins Comprising Ribosome-Inactivating Proteins
Patent: 6,146,631 →
Application: 08/839,765 →
Therapeutic Uses of Bpi Protein Products in Humans with Hemorrhage Due to Trauma
Patent: 5,945,399 →
Application: 08/862,785 →
Three-Dimensional Structure of Bacteria/Permeability Increasing Protein (Bpi)
Patent: 6,093,573 →
Application: 08/879,565 →
Therapeutic Uses of Bpi Protein Products for Human Meningococcemia
Patent: 5,888,977 →
Application: 08/927,437 →
Uses of Lipopolysaccharide Binding Protein
Patent: 5,990,082 →
Application: 08/955,660 →
Proteins Encoding Gelonin Sequences
Patent: 6,146,850 →
Application: 09/136,389 →
Improved Methods for Recombinant Peptide Production
Patent: 6,242,219 →
Application: 09/271,970 →
Therapeutic Uses of Bpi Protein Products in Bpi-Deficient Humans
Patent: 6,153,584 →
Application: 09/285,124 →
Bactericidal/Permeability-Increasing Protein(Bpi) Deletion Analogs
Patent: 6,087,126 →
Application: 09/336,402 →
Derivative Compounds Derived from or Based on Bactericidal/Permeability-Increasing Protein
Patent: 6,355,616 →
Application: 09/344,541 →
Therapeutic Derivative Compounds Derived from Domain Ii of Bactericidal/Permeability-Increasing Protein
Patent: 6,423,825 →
Application: 09/344,827 →
Identification of Novel Antimicrobial Agents Using Membrane Potential Indicator Dyes
Patent: 6,143,516 →
Application: 09/404,926 →
Method of Treating Chronic Cardiac Disease
Patent: 6,509,317 →
Application: 09/488,979 →
Therapeutic Uses of Bpi Protein Products in Bpi-Deficient Humans
Patent: 6,376,465 →
Application: 09/541,821 →
Identification of Novel Antimicrobial Agents Using Metabolic Oxidation-Reduction Indicator Dyes
Patent: 6,436,660 →
Application: 09/543,955 →
Agents and Methods for Inhibiting F1/F0 Atpase
Patent: 6,376,211 →
Application: 09/545,112 →
Bactericidal/Permeability-Increasing Protein (Bpi) Deletion Analogs
Patent: 6,599,880 →
Application: 09/579,403 →
Therapeutic Uses of Bpi Protein Products in Humans with Otitis Media with Effusion
Patent: 6,670,327 →
Application: 09/586,850 →
Fusion Proteins and Polynucleotides Encoding Gelonin Sequences
Patent: 6,376,217 →
Application: 09/610,838 →
Immunotoxins Comprising Ribosome-Inactivating Proteins
Patent: 6,649,742 →
Application: 09/711,485 →
Methods and Cells for Expression of Recombinant Protein Products Under the Transcriptional Control of an Inducible Promoter
Patent: 6,803,210 →
Application: 09/811,933 →
Publication: US 2002/0037552
Treatment Method
Patent: 6,582,698 →
Application: 09/819,921 →
Treatment of Lfa-1 Associated Disorders with Increasing Doses of Lfa-1 Antagonist
Patent: 6,652,855 →
Application: 09/936,603 →
Antifungal compound
Application: 09/975,638 →
Publication: US 2003/0166528
Modulation of pericyte proliferation
Application: 10/006,557 →
Publication: US 2002/0173464
Modular assembly of antibody genes, antibodies prepared thereby and use
Application: 10/040,945 →
Publication: US 2003/0096343
Eukaryotic Signal Sequences for Prokaryotic Expression
Patent: 7,094,579 →
Application: 10/076,802 →
Publication: US 2003/0162249
Therapeutic Uses of Bpi Protein Products in Bpi-Deficient Humans
Patent: 7,041,644 →
Application: 10/128,139 →
Publication: US 2003/0027762
Production of chimeric mouse-human antibodies with specificity to human tumor antigens
Application: 10/263,182 →
Publication: US 2005/0196400
Eukaryotic Signal Sequences for Polypeptide Expression and Polypeptide Display Libraries
Patent: 7,396,661 →
Application: 10/367,169 →
Publication: US 2003/0228660
Methods and Materials for Increasing Expression of Recombinant Polypeptides
Patent: 7,192,737 →
Application: 10/404,724 →
Publication: US 2003/0203447
M-csf specific monoclonal antibody and uses thereof
Application: 10/585,459 →
Publication: US 2009/0324604
Bacterical/permability-increasing protein(BPI) deletion analogs
Application: 10/629,516 →
Publication: US 2005/0130889
Human engineered antibodies to Ep-CAM
Application: 10/816,276 →
Publication: US 2005/0009097
Treatment of Lfa-1 Associated Disorders with Increasing Doses of Lfa-1 Antagonist
Patent: 7,364,734 →
Application: 11/078,332 →
Publication: US 2005/0169916
Methods and materials for expression of a recombinant protein
Application: 11/295,006 →
Publication: US 2006/0121604
Substituted Quinazolinones for Treating Neurological Conditions
Patent: 8,084,459 →
Application: 11/547,056 →
Publication: US 2008/0119470
Methods and Materials for Increasing Expression of Recombinant Polypeptides
Patent: 7,993,915 →
Application: 11/673,539 →
Publication: US 2007/0281334
Methods for Recombinant Peptide Production
Patent: 7,749,731 →
Application: 11/762,486 →
Publication: US 2009/0246831
Methods and Materials for Expression of a Recombinant Protein
Patent: 7,794,976 →
Application: 11/831,691 →
Publication: US 2008/0145894
EPHB3-Specific Antibody and Uses Thereof
Patent: 8,586,716 →
Application: 11/833,726 →
Publication: US 2009/0142261
Methods and Materials for Increasing Expression of Recombinant Polypeptides
Application: 11/835,131 →
Publication: US 2008/0145895
Prlr-Specific Antibody and Uses Thereof
Patent: 7,867,493 →
Application: 11/840,267 →
Publication: US 2008/0292620
Methods of Monitoring the Efficacy of Anti-CD40 Antibodies in Treating a Subject Having an Inflammatory or Autoimmune Disease
Patent: 8,333,970 →
Application: 11/914,710 →
Publication: US 2008/0274118
Methods of Monitoring the Efficacy of Anti-CD40 Antibodies in Treating a Subject for a CD40-Expessing Cancer
Patent: 8,337,851 →
Application: 11/914,714 →
Publication: US 2009/0041773
Antagonist Anti-CD40 Antibodies
Patent: 8,277,810 →
Application: 11/932,472 →
Publication: US 2008/0254026
Nucleic acids encoding Human Engineered heavy and light chain variable region sequences to Ep-CAM
Application: 11/934,701 →
Publication: US 2008/0241126
M-Csf-Specific Monoclonal Antibody and Uses Thereof
Patent: 8,652,469 →
Application: 11/996,905 →
Publication: US 2010/0092464
Uses Of Antibody To M-Csf
Application: 11/996,909 →
Publication: US 2008/0233118
Eukaryotic Signal Sequences for Polypeptide Expression and Polypeptide Display Libraries
Patent: 7,977,068 →
Application: 12/020,482 →
Publication: US 2008/0214411
Eukaryotic Signal Sequences for Polypeptide Expression and Polypeptide Display Libraries
Patent: 7,972,811 →
Application: 12/021,098 →
Publication: US 2010/0009857
Treatment of Cancer or Pre-Malignant Conditions Using Anti-CD40 Antibodies
Patent: 8,926,979 →
Application: 12/092,247 →
Publication: US 2009/0117111
Uses of Anti-CD40 Antibodies
Application: 12/092,256 →
Publication: US 2009/0202531
Methods for Preventing and Treating Cancer Metastasis and Bone Loss Associated with Cancer Metastasis
Application: 12/159,665 →
Publication: US 2009/0246208
Human Antibodies Specific for Gastrin Materials and Methods
Patent: 8,278,421 →
Application: 12/293,890 →
Publication: US 2009/0311257
Antagonist Antibodies Against EPHB3
Patent: 8,377,439 →
Application: 12/312,837 →
Publication: US 2010/0098711
Fully Human Anti-Vegf Antibodies and Methods of Using
Application: 12/446,438 →
Publication: US 2011/0076279
Novel Triple Tag Sequence and Methods of Use Thereof
Patent: 8,546,307 →
Application: 12/572,877 →
Publication: US 2010/0184612
Fully Human Anti-Vegf Antibodies and Methods of Using
Patent: 8,216,571 →
Application: 12/739,383 →
Publication: US 2011/0097340
Treatment of Diseases or Conditions Associated with Neoplastic B-Cell Growth Using Anti-CD40 Antibodies and Chop
Application: 12/741,161 →
Publication: US 2011/0002934
Cardiovascular Related Uses of Il-1BETA Antibodies and Binding Fragments Thereof
Application: 12/790,738 →
Publication: US 2010/0316651
Methods and Materials for Targeted Mutagenesis
Patent: 9,102,711 →
Application: 12/811,331 →
Publication: US 2011/0118131
Anti-Botulism Antibody Coformulations
Patent: 8,821,879 →
Application: 12/875,065 →
Publication: US 2012/0121581
Antibody Coformulations
Application: 12/875,083 →
Publication: US 2011/0059079
Screening Methods
Patent: 9,885,711 →
Application: 12/890,590 →
Publication: US 2011/0274692
PRLR-Specific Antibody and Uses Thereof
Patent: 9,005,614 →
Application: 12/951,744 →
Publication: US 2011/0150760
Methods for the Treatment of Rheumatoid Arthritis
Application: 12/996,516 →
Publication: US 2011/0189172
Hepatocyte Growth Factor (Hgf) Binding Proteins
Patent: 8,273,355 →
Application: 13/051,481 →
Publication: US 2011/0229462
Eukaryotic Signal Sequences for Polypeptide Expression and Polypeptide Display Libraries
Patent: 8,476,040 →
Application: 13/112,600 →
Publication: US 2011/0224102
Methods and Materials for Increasing Expression of Recombinant Polypeptides
Patent: 8,497,096 →
Application: 13/205,448 →
Publication: US 2012/0178126
Novel Triple Tag Sequences and Methods of Use Thereof
Patent: 8,546,308 →
Application: 13/244,871 →
Publication: US 2012/0010101
Methods and Apparatus for Improving Healthcare
Patent: 8,738,398 →
Application: 13/284,423 →
Antibodies to High Molecular Weight Melanoma Associated Antigen
Patent: 8,318,162 →
Application: 13/384,197 →
Publication: US 2012/0171226
Antibodies Specific for TGF-Beta and Methods for Treating Thereof
Patent: 8,569,462 →
Application: 13/486,983 →
Publication: US 2012/0315282
Hepatocyte Growth Factor (Hgf) Binding Proteins
Patent: 8,580,930 →
Application: 13/589,664 →
Publication: US 2013/0203963
Antagonist Anti-CD40 Monoclonal Antibodies and Methods for Their Use
Patent: 8,637,032 →
Application: 13/612,070 →
Publication: US 2013/0011405
Antagonist Antibodies Against EPHB3
Patent: 8,961,969 →
Application: 13/724,312 →
Publication: US 2013/0108638
Methods and Materials for Enhancing Functional Protein Expression in Bacteria
Patent: 9,732,143 →
Application: 13/982,669 →
Publication: US 2014/0154743
Cell Surface Display Using Pdz Domains
Application: 13/995,611 →
Publication: US 2014/0038842
Antibodies Specific for TGF-Beta and Methods of Treatment Thereof
Patent: 9,145,458 →
Application: 14/038,436 →
Publication: US 2014/0023644
Nucliec Acid Encoding Hepatocyte Growth Factor (Hgf) Binding Proteins
Patent: 9,096,664 →
Application: 14/044,278 →
Publication: US 2014/0178935
EPHB3-Specific Antibody and Uses Thereof
Patent: 9,006,398 →
Application: 14/055,376 →
Publication: US 2014/0148584
M-Csf Specific Monoclonal Antibody and Uses Thereof
Patent: 9,079,956 →
Application: 14/171,330 →
Publication: US 2014/0242071
Methods and Apparatus for Improving Healthcare
Application: 14/255,089 →
Publication: US 2015/0025901
Antagonist Antibodies Against EPHB3
Patent: 9,541,004 →
Application: 14/592,115 →
Publication: US 2015/0183872
Methods and Apparatus for Improving Healthcare
Application: 14/606,596 →
Publication: US 2015/0161352
Methods and Apparatus for Improving Healthcare
Application: 14/606,732 →
Publication: US 2015/0161353
M-Csf Specific Monoclonal Antibody and Uses Therof
Patent: 9,522,186 →
Application: 14/729,548 →
Publication: US 2016/0015809
Tgf-Beta-Specific Antibodies and Methods of Use Thereof for Treatment
Patent: 9,714,285 →
Application: 14/808,666 →
Publication: US 2015/0322146
Treatment of Cancer Using Anti-TGF-BETA and PD-1 Antibodies
Application: 15/089,579 →
Publication: US 2016/0289315
M-Csf Specific Monoclonal Antibody and Uses Thereof
Patent: 9,926,371 →
Application: 15/347,171 →
Publication: US 2017/0152311
Nucleic Acids Encoding, and Methods of Producing, Antibodies Specific for Transforming Growth Factor (TGF)-Beta
Application: 15/622,955 →
Publication: US 2018/0057578
Screening Methods
Application: 15/886,188 →
Publication: US 2018/0231545
Treatment Method
Application: 60/125,228 →
Treatment Method
Application: 60/125,351 →
Methods and materials for increasing expression of recombinant polypeptides
Application: 60/368,530 →
Antagonist anti-CD40 monoclonal antibodies and methods for their use
Application: 60/517,337 →
M-CSF-specific monoclonal antibody and uses thereof
Application: 60/535,181 →
Antagonist anti-CD40 monoclonal antibodies and methods for their use
Application: 60/565,710 →
M-CSF-specific monoclonal antibody and uses thereof
Application: 60/576,417 →
Methods and materials for transient expression of a recombinant protein
Application: 60/633,056 →
Uses of antibody to M-CSF
Application: 60/703,191 →
M-CSF-specific monoclonal antibody and uses thereof
Application: 60/703,218 →
M-CSF-specific monoclonal antibody and uses thereof
Application: 60/703,314 →
Soluble human M-CSF receptor and uses thereof
Application: 60/753,218 →
Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
Application: 60/756,944 →
Human antibodies specific for gastrin materials and methods
Application: 60/784,501 →
Soluble human M-CSF receptor and uses thereof
Application: 60/786,131 →
Associations of single nucleotide polymorphisms (SNP) and polymorphic haplotypes in bovine genes associated with economically relevant traits
Application: 60/836,777 →
PRLR-specific antibody and uses thereof
Application: 60/838,648 →
Antagonist antibodies against EphB3
Application: 60/873,386 →
Prlr-Specific Antibody and Uses Thereof
Application: 60/946,360 →
Libraries and Their Uses for Targeted Affinity Enhancement
Application: 61/018,101 →
Arrays and Their Uses for Targeted Affinity Enhancement
Application: 61/018,105 →
Methods and Materials for Targeted Affinity Enhancement
Application: 61/018,113 →
Novel Triple Tag Sequence and Methods of Use Thereof
Application: 61/102,672 →
Novel Triple Tag Sequence and Methods of Use Thereof
Application: 61/102,675 →
Antibodies to High Molecular Weight Melanoma Associated Antigen
Application: 61/226,166 →
Anti-Botulism Antibody Coformulations
Application: 61/240,149 →
Antibody Coformulations
Application: 61/240,155 →
Screening Methods
Application: 61/246,079 →
Screening Methods
Application: 61/306,324 →
Methods and Materials for Enhancing Functional Protein Expression in Bacteria
Application: 61/439,232 →
Antibodies Specific for TGF-Beta
Application: 61/493,230 →
Treatment of Cancer Using Inhibitors of TGF-Beta and PD-1
Application: 62/143,016 →
Treatment of Cancer Using Inhibitors of Tgf-Beta and Pd-1
Application: 62/191,797 →
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Dec 10, 2007
From: LVB ACQUISITION, INC.; BIOMET, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT FOR THE SECURED PARTIES
Reel/Frame 020362/0001 →
Assignment of Assignor's Interest Feb 1, 2010
From: RONDON, ISAAC; ROELL, MARINA; BEDINGER, DANIEL
To: XOMA TECHNOLOGY LTD.
Reel/Frame 023878/0360 →
Assignment of Assignor's Interest Sep 20, 2012
From: BEDINGER, DANIEL H.; KAHN, SHIREEN S.; MIRZA, AMER M.; NARASIMHA, AJAY J.
To: XOMA TECHNOLOGY LTD.
Reel/Frame 028998/0960 →
Assignment of Assignor's Interest Jun 26, 2014
From: LEVY, RAPHAEL DAVID; CHAN, CHUNG-LEUNG; AHLUWALIA, KIRANJIT KAUER; TAKEUCHI, TOSHIHIKO
To: XOMA TECHNOLOGY LTD.
Reel/Frame 033184/0851 →
Assignment of Assignor's Interest Oct 30, 2015
From: HORWITZ, ARNOLD H.
To: XOMA TECHNOLOGY LTD.
Reel/Frame 036928/0067 →
Assignment of Assignor's Interest Oct 30, 2015
From: WHITE, MARK; ROELL, MARINA; CORBIN, JOHN A.; BAUER, ROBERT J.
To: XOMA TECHNOLOGY LTD.
Reel/Frame 036923/0184 →
Release of Security Interest in Patents Recorded at Reel 020362/ Frame 0001 Nov 23, 2015
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: LVB ACQUISITION, INC.; BIOMET, INC.
Reel/Frame 037155/0133 →
Assignment of Assignor's Interest Aug 4, 2016
From: MIRZA, AMER M.; LI, OU
To: XOMA TECHNOLOGY LTD.
Reel/Frame 039345/0650 →
Assignment of Assignor's Interest Aug 4, 2016
From: AKHURST, ROSEMARY J.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 039345/0464 →
Security Interest May 9, 2018
From: XOMA TECHNOLOGY LTD.
To: SILICON VALLEY BANK
Reel/Frame 046115/0459 →
Assignment of Assignor's Interest Feb 19, 2026
From: XOMA TECHNOLOGY LTD.
To: XOMA (US) LLC
Reel/Frame 073831/0803 →